Assessment of reported adverse events after substitution between TNF alfa inhibitors biosimilars in the WHO pharmacovigilance database

被引：0

作者：

Orhon, P. ^{[1
]}

Robert, M. ^{[1
]}

Bernardeau, C. ^{[1
]}

Fusaroli, M. ^{[2
]}

Roustit, M. ^{[3
]}

Cracowski, J. L. ^{[1
]}

Khouri, C. ^{[1
]}

机构：

[1] Grenoble Alpes Univ Hosp, Pharmacovigilance Unit, Grenoble, France

[2] Dept Med & Surg Sci, Pharmacol Unit, Bologna, Italy

[3] Grenoble Alpes Univ Hosp, Clin Pharmacol Dept, Grenoble, France

来源：

FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2023年 / 37卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

PS-115

引用

页码：160 / 160

页数：1

共 50 条

[21] Neurological and related adverse events in immune checkpoint inhibitors: a pharmacovigilance study from the Japanese Adverse Drug Event Report database [J].

Kenichiro Sato ;

Tatsuo Mano ;

Atsushi Iwata ;

Tatsushi Toda .

Journal of Neuro-Oncology, 2019, 145 :1-9

[22] Neurological and related adverse events in immune checkpoint inhibitors: a pharmacovigilance study from the Japanese Adverse Drug Event Report database [J].

Sato, Kenichiro ;

Mano, Tatsuo ;

Iwata, Atsushi ;

Toda, Tatsushi .

JOURNAL OF NEURO-ONCOLOGY, 2019, 145 (01) :1-9

[23] Hepatotoxic adverse events with immune checkpoint inhibitors: Real world pharmacovigilance study using FAERS database. [J].

Parab, Panah Tushar ;

Vojjala, Nikhil ;

Bhanushali, Charmi ;

Maryam, Bibi ;

Prabhu, Rishab R. ;

Patan, Shajadi ;

Tripathi, Sharanya ;

Ahmed, Nausheen .

JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (16_SUPPL)

[24] Thrombotic adverse events associated with TNF-alpha blockers: a real-world pharmacovigilance analysis of the FAERS database [J].

Song, Lijuan ;

Yang, Nan ;

Xing, Xinglong ;

Zhao, Yicong ;

Di, Jingkai .

FRONTIERS IN PHARMACOLOGY, 2025, 16

[25] OPHTHALMOLOGICAL ADVERSE EVENTS UNDER JAK INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS: CASE ANALYSIS OF THE EUROPEAN PHARMACOVIGILANCE DATABASE [J].

Hecquet, Sophie ;

Rabier, Marie Blanche ;

Lepelley, Marion ;

Verhoeven, Frank ;

Gauthier, Anne Sophie ;

Prati, Clement ;

Delbosc, Bernard ;

Wendling, Daniel .

ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 :748-748

[26] Cardiovascular adverse events associated with JAK inhibitor versus TNF inhibitor: A disproportionality analysis in national pharmacovigilance database of Korea [J].

Yoon, Jinkyoung ;

Yang, Bo Ram .

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 :475-475

[27] Pharmacovigilance assessment of the association between Fournier's gangrene and other severe genital adverse events with SGLT-2 inhibitors [J].

Fadini, Gian Paolo ;

Sarangdhar, Mayur ;

De Ponti, Fabrizio ;

Avogaro, Angelo ;

Raschi, Emanuel .

BMJ OPEN DIABETES RESEARCH & CARE, 2019, 7 (01)

[28] Antibiotics-Induced Liver Injury: A Pharmacovigilance Study Using a Measure of Disproportionality in a Database of Spontaneously Reported Adverse Events [J].

Mendes, D. ;

Dias, P. ;

Alves, C. ;

Batel-Marques, F. .

DRUG SAFETY, 2015, 38 (10) :1006-1006

[29] Safety profiles of adalimumab, etanercept and infliximab: a pharmacovigilance study using a measure of disproportionality in a database of spontaneously reported adverse events [J].

Mendes, D. ;

Alves, C. ;

Batel-Marques, F. .

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2014, 39 (03) :307-313

[30] Serious adverse events reported with benzimidazole derivatives: A disproportionality analysis from the World Health Organization's pharmacovigilance database [J].

Modingam, Pamella ;

Faillie, Jean-Luc ;

Campillo, Jeremy T. .

PLOS NEGLECTED TROPICAL DISEASES, 2024, 18 (11)

← 1 2 3 4 5 →